By Uri Shine The potential for psychedelics to treat mental health is no longer a secret held by counterculturalists and underground therapists. Research from top universities has established the benefits of...
This year’s pitch event wound up in a dramatic finish! Following pitches from four businesses, the judges selected Reagenics as the winner. While maintaining his title and bragging rights, Reagenics CEO and Co...
PsyTech is thrilled to announce that we’ve been acquired by Wesana Health, an established company in the psychedelics wellness space with a focus on the development of psychedelics and other medicines for the...
By Tessa Eskin It was the spring of 1943. Albert Hofmann was in his lab, revisiting a shelved research project on the ergot fungus. He was on the hunt for a compound to stimulate the respiratory and circulatory systems...
By Brian Lissak Ketamine has become a first-line defense against depression. Thanks to its rapid-acting nature and higher efficacy rates when compared to SSRIs, ketamine received FDA approval on March 5, 2019. Hailed by...
